viernes, 17 de agosto de 2018

NHLBI Funding & Research Opportunities and Announcements for August 3, 2018

NHLBI_Standard_Sig_Logo_RGB - New

Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices

Update - NIH Response to Registration Issues in Sam.gov
(NOT-OD-18-215) National Institutes of Health
Notice of NIAID Participation in PA-18-393 "Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Clinical Trial Required)"
(NOT-AI-18-050)
National Institute of Allergy and Infectious Diseases
Notice of Change to Criteria for RFA-HL-19-017 "NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases"
(NOT-HL-18-633)
National Heart, Lung, and Blood Institute
Notice of Information to the Specific Areas of Research Interest for PAR-16-021 "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01)"
(NOT-HL-18-644)
National Heart, Lung, and Blood Institute

Requests for Applications

Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Studies (Collaborative U01 Clinical Trial Not Allowed)
(RFA-HL-18-030)
National Heart, Lung, and Blood Institute

Regenerative Medicine Innovation Projects (RMIP) Investigator-Initiated Clinical Trials (UG3/UH3 Clinical Trial Required)
(RFA-HL-18-031)
National Heart, Lung, and Blood Institute
Regenerative Medicine Innovation Projects (RMIP) (UT2 - Clinical Trial Not Allowed)
(RFA-HL-18-033)
National Heart, Lung, and Blood Institute
Regenerative Medicine Innovation Projects (RMIP) (U44 - Clinical Trial Not Allowed)
(RFA-HL-18-035)
National Heart, Lung, and Blood Institute
Management of Asthma in Primary Care - Clinical Center (UG3/UH3 - Clinical Trial Required)
(RFA-HL-19-005)
National Heart, Lung, and Blood Institute
Management of Asthma in Primary Care - Bioinformatics Center (U24 - Clinical Trial Required - Infrastructure)
(RFA-HL-19-006)
National Heart, Lung, and Blood Institute
Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
(RFA-NS-18-041)
National Heart, Lung, and Blood Institute

No hay comentarios: